Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting

MeSH terms

• Angioplasty / adverse effects
• Angioplasty / economics*
• Angioplasty / instrumentation*
• Angioplasty / legislation & jurisprudence
• Carotid Artery Diseases / economics*
• Carotid Artery Diseases / therapy*
• Centers for Medicare and Medicaid Services, U.S. / economics*
• Centers for Medicare and Medicaid Services, U.S. / legislation & jurisprudence
• Evidence-Based Medicine
• Health Policy / economics*
• Humans
• Insurance, Health, Reimbursement* / legislation & jurisprudence
• Patient Selection
• Policy Making
• Risk Assessment
• Risk Factors
• Stents / economics*
• United States